What Does BI-RADS 4 Mean?

BI-RADS stands for Breast Imaging Reporting and Data System. It exists so that radiologists in different centers describe the same finding the same way. Every mammogram, breast ultrasound, and breast MRI report ends with one assessment number from 0 to 6.

Category 4 means suspicious. It means the imaging features carry enough chance of cancer that tissue should be sampled, but not enough to call it cancer. StatPearls defines it as a suspicious abnormality with a stated percent chance of being malignant.

The range behind that word is enormous. A category 4 finding can carry a 3 percent chance of cancer or an 80 percent chance. That is why the letter after the number matters more than the number itself.

The American College of Radiology splits category 4 into three bands by likelihood of malignancy:

• 4A, low suspicion: more than 2 percent up to 10 percent
• 4B, moderate suspicion: more than 10 percent up to 50 percent
• 4C, high suspicion: more than 50 percent up to just under 95 percent

A 4A finding is more likely benign than not. Roughly nine out of ten turn out to be nothing. A 4C finding is the opposite.

This is the part most patients never hear. A study of the National Mammography Database looked at 125,447 diagnostic mammograms assessed as category 4. Radiologists used a subdivision in only 33.3 percent of them.

Among the reports that were subdivided, 4A accounted for 55.6 percent, 4B for 31.8 percent, and 4C for 12.6 percent. So when a letter is assigned, it is most often the lowest-suspicion one.

The observed cancer yields matched the published expectations closely. In that database, pathology confirmed cancer in 7.6 percent of 4A findings, 22.2 percent of 4B findings, and 69.3 percent of 4C findings. Outcomes were available for 91,563 exams, about 73 percent of the group.

If your report says only "BI-RADS 4" with no letter, it is reasonable to call the imaging center and ask whether the radiologist would assign a subdivision. The answer changes what the waiting period feels like, and sometimes how quickly the biopsy is scheduled.

Reading the whole scale makes the boundaries clearer:

• 0: incomplete. More imaging is needed before any judgment.
• 1: negative. No masses, suspicious calcifications, or architectural distortion.
• 2: benign findings, such as secretory calcifications, simple cysts, or fat-containing lesions. Routine screening continues.
• 3: probably benign. Risk of cancer under 2 percent. The usual plan is a follow-up scan in six months rather than a biopsy.
• 4: suspicious. Biopsy is recommended.
• 5: highly suggestive of cancer, above 95 percent. Biopsy is strongly recommended.
• 6: cancer already proven by pathology. Used to track response to treatment.

The gap between 3 and 4 is the one that decides whether a needle is involved. Under 2 percent means watch. Over 2 percent means sample.

Your report also grades breast composition into one of four categories: almost entirely fatty, scattered areas of fibroglandular density, heterogeneously dense, or extremely dense.

Density is not part of the assessment number. Dense tissue can hide a lesion on mammography, which is why an ultrasound is sometimes added. But a dense breast alone does not create a category 4.

Image guidance is chosen to match how the finding is best seen. Ultrasound guidance is common for masses visible on ultrasound. Stereotactic guidance uses mammography and is standard for calcifications that only show on a mammogram. MRI guidance is used when the finding was only visible on MRI.

The needle itself varies. A vacuum-assisted device uses suction to draw tissue into the needle, and RadiologyInfo notes that three to twelve samples are typically taken, depending on the device.

The procedure is usually completed within an hour. This is not surgery, and it does not require general anesthesia.

Most people are surprised by this step. A small marker is often placed at the biopsy site so the spot can be found again later, whether for surgery or for comparison on a future scan.

Two common worries are answered directly by RadiologyInfo. Biopsy markers are MRI compatible, and they will not set off metal detectors.

Avoid strenuous activity for at least 24 hours. For swelling or bruising, RadiologyInfo suggests an over-the-counter pain reliever and a cold pack.

Ask for written aftercare instructions before you leave, since centers differ on details like when to shower and when to resume blood thinners.

• Does my report assign 4A, 4B, or 4C? If not, would you assign one?
• Which imaging guidance will be used, and why that one for my finding?
• Will a marker clip be placed?
• Does the pathology result fit what you saw on the images? If it does not, what happens next?
• If this comes back benign, what is my follow-up imaging schedule and when?

That fourth question matters. A benign biopsy result that does not match a highly suspicious image is a reason for the team to keep looking, not to close the file.

Most of what follows relates to the biopsy, not to the category itself. A BI-RADS 4 report is not by itself an emergency.

• Call 911 or go to an emergency department if bleeding from the biopsy site will not stop with firm pressure, or you feel faint, breathless, or have chest pain afterward.
• Call the imaging center or your care team the same day if you develop a temperature of 100.4°F (38°C) or higher, or spreading redness, warmth, or increasing pain at the biopsy site. These can point to infection.
• Call the imaging center or your care team the same day if blood soaks through a dressing, or a firm lump at the site keeps getting bigger.
• Call your care team within a day or two if you have not been told when or how you will get the pathology result, or the promised date passes with no word. Chasing a result is reasonable, not pushy.

https://www.ncbi.nlm.nih.gov/books/NBK459169/

https://pmc.ncbi.nlm.nih.gov/articles/PMC6413875/

https://www.radiologyinfo.org/en/info/article-breast-imaging-report

https://www.radiologyinfo.org/en/info/breastbixr